One year after the US Centers for Disease Control and Prevention issued its first recommendations for adult respiratory syncytial virus vaccines, its Advisory Committee for Immunization Practices agreed to move away from the unwieldy original shared clinical decision-making policy in favor of a combination of a risk-based and age-based recommendations.
Key Takeaways
-
The CDC’s Advisory Committee on Immunization Practices revisited its adult respiratory syncytial virus vaccine recommendations, unanimously voting to change the year-old shared clinical decision-making recommendation for people 75 and older.
The ACIP voted 11-0 on 26 June in favor of a universal recommendation that adults 75 years of age and...
